Euthymics Bioscience
  • Home
  • Our Family of Companies
    • Euthymics Bioscience: Major Depressive Disorder and Amitifadine
    • Neurovance: ADHD and EB-1020
  • Our Technology
  • About
    • About Euthymics
    • Management
    • Board of Directors
  • Contact
  • News

News

  • News
    • Corporate Fact Sheet
    • In The News
    • Press Releases
    • Publications
Home    >    Publications

Publications

December 8, 2010 - Efficacy and Safety of the Novel Triple Reuptake Inhibitor EB-1010 in the Treatment of Patients with Major Depressive Disorder


December 6, 2010 - Effects of the Unbalanced Triple Transporter Inhibitor EB-1010 on Monoamine Uptake Transporters in Vitro and in Vivo


Privacy Policy  |  Terms of Use Copyright ©2013 Euthymics Bioscience. All Rights Reserved.